Παρακολούθηση
Clio P. Mavragani
Clio P. Mavragani
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα med.uoa.gr
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Sjögren’s syndrome
CP Mavragani, GE Fragoulis, HM Moutsopoulos
The Autoimmune Diseases, 495-510, 2014
4882014
The geoepidemiology of Sjögren's syndrome
CP Mavragani, HM Moutsopoulos
Autoimmunity reviews 9 (5), A305-A310, 2010
4082010
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies
M Dastmalchi, C Grundtman, H Alexanderson, CP Mavragani, ...
Annals of the rheumatic diseases 67 (12), 1670-1677, 2008
2912008
Type I and II interferon signatures in Sjogren's syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis
A Nezos, F Gravani, A Tassidou, EK Kapsogeorgou, M Voulgarelis, ...
Journal of autoimmunity 63, 47-58, 2015
2672015
Predicting the risk for lymphoma development in Sjogren syndrome: an easy tool for clinical use
S Fragkioudaki, CP Mavragani, HM Moutsopoulos
Medicine 95 (25), e3766, 2016
2392016
Cardiovascular disease in systemic lupus erythematosus: a comprehensive update
M Giannelou, CP Mavragani
Journal of autoimmunity 82, 1-12, 2017
1982017
Activation of the type I interferon pathway in primary Sjogren’s syndrome
CP Mavragani, MK Crow
Journal of autoimmunity 35 (3), 225-231, 2010
1922010
Augmented interferon‐α pathway activation in patients with Sjögren's syndrome treated with etanercept
CP Mavragani, TB Niewold, NM Moutsopoulos, SR Pillemer, SM Wahl, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2007
1872007
Expression of long interspersed nuclear element 1 retroelements and induction of type I interferon in patients with systemic autoimmune disease
CP Mavragani, I Sagalovskiy, Q Guo, A Nezos, EK Kapsogeorgou, P Lu, ...
Arthritis & rheumatology 68 (11), 2686-2696, 2016
1732016
Central nervous system involvement in Sjögren’s syndrome
FC Soliotis, CP Mavragani, HM Moutsopoulos
Annals of the rheumatic diseases 63 (6), 616-620, 2004
1712004
The management of Sjögren's syndrome
CP Mavragani, NM Moutsopoulos, HM Moutsopoulos
Nature clinical practice Rheumatology 2 (5), 252-261, 2006
1692006
Sjögren's syndrome: old and new therapeutic targets
CP Mavragani, HM Moutsopoulos
Journal of autoimmunity 110, 102364, 2020
1482020
B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome
A Nezos, A Papageorgiou, G Fragoulis, D Ioakeimidis, M Koutsilieris, ...
Journal of autoimmunity 51, 89-98, 2014
1322014
Predicting the outcome of Sjogren’s syndrome-associated non-hodgkin’s lymphoma patients
A Papageorgiou, DC Ziogas, CP Mavragani, E Zintzaras, AG Tzioufas, ...
PloS one 10 (2), e0116189, 2015
1242015
Conventional therapy of Sjogren’s syndrome
CP Mavragani, HM Moutsopoulos
Clinical reviews in allergy & immunology 32, 284-291, 2007
1082007
Endocrine alterations in primary Sjogren's syndrome: an overview
CP Mavragani, GE Fragoulis, HM Moutsopoulos
Journal of autoimmunity 39 (4), 354-358, 2012
1072012
Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren’s syndrome: prevalence, clinical and laboratory associations
F Gravani, I Papadaki, E Antypa, A Nezos, K Masselou, D Ioakeimidis, ...
Arthritis research & therapy 17, 1-13, 2015
1022015
Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon‐β/α ratios in rheumatoid arthritis patients: a post hoc …
CP Mavragani, DT La, W Stohl, MK Crow
Arthritis & Rheumatism: Official Journal of the American College of …, 2010
1022010
Mechanisms and new strategies for primary Sjögren's syndrome
CP Mavragani
Annual Review of Medicine 68 (1), 331-343, 2017
962017
Stress, coping strategies and social support in patients with primary Sjögren’s syndrome prior to disease onset: a retrospective case–control study
D Karaiskos, CP Mavragani, S Makaroni, E Zinzaras, M Voulgarelis, ...
Annals of the rheumatic diseases 68 (1), 40-46, 2009
962009
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20